Long Term Debt - Gensight Biologics SA (PAR:SIGHT) - Alpha Spread

Gensight Biologics SA
PAR:SIGHT

Watchlist Manager
Gensight Biologics SA Logo
Gensight Biologics SA
PAR:SIGHT
Watchlist
Price: 0.38 EUR -3.8%
Market Cap: 39.3m EUR
Have any thoughts about
Gensight Biologics SA?
Write Note

Gensight Biologics SA
Long-Term Debt

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Gensight Biologics SA
Long-Term Debt Peer Comparison

Comparables:
VLA
NANO
IPH
GNFT
ALERS

Competitive Long-Term Debt Analysis
Latest Figures & CAGR of Competitors

Company Long-Term Debt CAGR 3Y CAGR 5Y CAGR 10Y
Gensight Biologics SA
PAR:SIGHT
Long-Term Debt
€6.2m
CAGR 3-Years
-28%
CAGR 5-Years
12%
CAGR 10-Years
N/A
Valneva SE
PAR:VLA
Long-Term Debt
€187.1m
CAGR 3-Years
23%
CAGR 5-Years
22%
CAGR 10-Years
11%
Nanobiotix SA
PAR:NANO
Long-Term Debt
€43.7m
CAGR 3-Years
2%
CAGR 5-Years
17%
CAGR 10-Years
48%
Innate Pharma SA
PAR:IPH
Long-Term Debt
€68.5m
CAGR 3-Years
9%
CAGR 5-Years
49%
CAGR 10-Years
33%
Genfit SA
NASDAQ:GNFT
Long-Term Debt
€62.3m
CAGR 3-Years
-30%
CAGR 5-Years
-18%
CAGR 10-Years
46%
Eurobio Scientific SA
PAR:ALERS
Long-Term Debt
€86.2m
CAGR 3-Years
79%
CAGR 5-Years
41%
CAGR 10-Years
50%

See Also

What is Gensight Biologics SA's Long-Term Debt?
Long-Term Debt
6.2m EUR

Based on the financial report for Dec 31, 2023, Gensight Biologics SA's Long-Term Debt amounts to 6.2m EUR.

What is Gensight Biologics SA's Long-Term Debt growth rate?
Long-Term Debt CAGR 5Y
12%

Over the last year, the Long-Term Debt growth was -60%. The average annual Long-Term Debt growth rates for Gensight Biologics SA have been -28% over the past three years , 12% over the past five years .

Back to Top